propofol has been researched along with urb 597 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Breitenbucher, JG; Seierstad, M | 1 |
| Krych, L; Moulton, K; Qin, M; Smith, CB; Xia, Z; Zeidler, Z | 1 |
| Fu, HL; Lu, Y; Sun, HJ; Wang, HW; Wang, SR; Xu, WY; Yang, F; Yao, XY; Yuan, HB; Zhang, H | 1 |
1 review(s) available for propofol and urb 597
| Article | Year |
|---|---|
Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors.
Topics: Amidohydrolases; Animals; Drug Discovery; Enzyme Inhibitors; Humans; Molecular Structure; Structure-Activity Relationship | 2008 |
2 other study(ies) available for propofol and urb 597
| Article | Year |
|---|---|
Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.
Topics: Amidohydrolases; Animals; Anxiety; Arachidonic Acids; Avoidance Learning; Benzamides; Cannabinoid Receptor Antagonists; Carbamates; Disease Models, Animal; Endocannabinoids; Enzyme Inhibitors; Fragile X Mental Retardation Protein; Fragile X Syndrome; Male; Memory; Mice, Inbred C57BL; Mice, Knockout; Piperidines; Polyunsaturated Alkamides; Propofol; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, GABA-A; Social Behavior | 2015 |
Activation of Endocannabinoid Receptor 2 as a Mechanism of Propofol Pretreatment-Induced Cardioprotection against Ischemia-Reperfusion Injury in Rats.
Topics: Animals; Apoptosis; Arachidonic Acids; Benzamides; Carbamates; Cells, Cultured; Endocannabinoids; Indoles; Male; Malondialdehyde; Myocardial Reperfusion Injury; Myocytes, Cardiac; Pentobarbital; Peroxidase; Propofol; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Signal Transduction; Superoxide Dismutase | 2017 |